Report Detail
Global PIVKA II Antigen Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4680275 |
- 26 February, 2026 |
- Global |
- 92 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global PIVKA II Antigen market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as Des-γ-carboxy-prothrombin (DCP), is an abnormal form of prothrombin.
This report is a detailed and comprehensive analysis for global PIVKA II Antigen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global PIVKA II Antigen market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PIVKA II Antigen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PIVKA II Antigen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PIVKA II Antigen market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PIVKA II Antigen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PIVKA II Antigen market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM, Labcorp, Abbexa, GenScript, Eisai, Sekbio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
PIVKA II Antigen market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Serum
Plasma
Others
Market segment by Application
Hospitals
Clinics
Others
Major players covered
FUJIFILM
Labcorp
Abbexa
GenScript
Eisai
Sekbio
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PIVKA II Antigen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PIVKA II Antigen, with price, sales quantity, revenue, and global market share of PIVKA II Antigen from 2021 to 2026.
Chapter 3, the PIVKA II Antigen competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PIVKA II Antigen breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and PIVKA II Antigen market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PIVKA II Antigen.
Chapter 14 and 15, to describe PIVKA II Antigen sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global PIVKA II Antigen Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Serum
- 1.3.3 Plasma
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global PIVKA II Antigen Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Others
- 1.5 Global PIVKA II Antigen Market Size & Forecast
- 1.5.1 Global PIVKA II Antigen Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global PIVKA II Antigen Sales Quantity (2021-2032)
- 1.5.3 Global PIVKA II Antigen Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 FUJIFILM
- 2.1.1 FUJIFILM Details
- 2.1.2 FUJIFILM Major Business
- 2.1.3 FUJIFILM PIVKA II Antigen Product and Services
- 2.1.4 FUJIFILM PIVKA II Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 FUJIFILM Recent Developments/Updates
- 2.2 Labcorp
- 2.2.1 Labcorp Details
- 2.2.2 Labcorp Major Business
- 2.2.3 Labcorp PIVKA II Antigen Product and Services
- 2.2.4 Labcorp PIVKA II Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Labcorp Recent Developments/Updates
- 2.3 Abbexa
- 2.3.1 Abbexa Details
- 2.3.2 Abbexa Major Business
- 2.3.3 Abbexa PIVKA II Antigen Product and Services
- 2.3.4 Abbexa PIVKA II Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Abbexa Recent Developments/Updates
- 2.4 GenScript
- 2.4.1 GenScript Details
- 2.4.2 GenScript Major Business
- 2.4.3 GenScript PIVKA II Antigen Product and Services
- 2.4.4 GenScript PIVKA II Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 GenScript Recent Developments/Updates
- 2.5 Eisai
- 2.5.1 Eisai Details
- 2.5.2 Eisai Major Business
- 2.5.3 Eisai PIVKA II Antigen Product and Services
- 2.5.4 Eisai PIVKA II Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Eisai Recent Developments/Updates
- 2.6 Sekbio
- 2.6.1 Sekbio Details
- 2.6.2 Sekbio Major Business
- 2.6.3 Sekbio PIVKA II Antigen Product and Services
- 2.6.4 Sekbio PIVKA II Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Sekbio Recent Developments/Updates
3 Competitive Environment: PIVKA II Antigen by Manufacturer
- 3.1 Global PIVKA II Antigen Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global PIVKA II Antigen Revenue by Manufacturer (2021-2026)
- 3.3 Global PIVKA II Antigen Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of PIVKA II Antigen by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 PIVKA II Antigen Manufacturer Market Share in 2025
- 3.4.3 Top 6 PIVKA II Antigen Manufacturer Market Share in 2025
- 3.5 PIVKA II Antigen Market: Overall Company Footprint Analysis
- 3.5.1 PIVKA II Antigen Market: Region Footprint
- 3.5.2 PIVKA II Antigen Market: Company Product Type Footprint
- 3.5.3 PIVKA II Antigen Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global PIVKA II Antigen Market Size by Region
- 4.1.1 Global PIVKA II Antigen Sales Quantity by Region (2021-2032)
- 4.1.2 Global PIVKA II Antigen Consumption Value by Region (2021-2032)
- 4.1.3 Global PIVKA II Antigen Average Price by Region (2021-2032)
- 4.2 North America PIVKA II Antigen Consumption Value (2021-2032)
- 4.3 Europe PIVKA II Antigen Consumption Value (2021-2032)
- 4.4 Asia-Pacific PIVKA II Antigen Consumption Value (2021-2032)
- 4.5 South America PIVKA II Antigen Consumption Value (2021-2032)
- 4.6 Middle East & Africa PIVKA II Antigen Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global PIVKA II Antigen Sales Quantity by Type (2021-2032)
- 5.2 Global PIVKA II Antigen Consumption Value by Type (2021-2032)
- 5.3 Global PIVKA II Antigen Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global PIVKA II Antigen Sales Quantity by Application (2021-2032)
- 6.2 Global PIVKA II Antigen Consumption Value by Application (2021-2032)
- 6.3 Global PIVKA II Antigen Average Price by Application (2021-2032)
7 North America
- 7.1 North America PIVKA II Antigen Sales Quantity by Type (2021-2032)
- 7.2 North America PIVKA II Antigen Sales Quantity by Application (2021-2032)
- 7.3 North America PIVKA II Antigen Market Size by Country
- 7.3.1 North America PIVKA II Antigen Sales Quantity by Country (2021-2032)
- 7.3.2 North America PIVKA II Antigen Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe PIVKA II Antigen Sales Quantity by Type (2021-2032)
- 8.2 Europe PIVKA II Antigen Sales Quantity by Application (2021-2032)
- 8.3 Europe PIVKA II Antigen Market Size by Country
- 8.3.1 Europe PIVKA II Antigen Sales Quantity by Country (2021-2032)
- 8.3.2 Europe PIVKA II Antigen Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific PIVKA II Antigen Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific PIVKA II Antigen Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific PIVKA II Antigen Market Size by Region
- 9.3.1 Asia-Pacific PIVKA II Antigen Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific PIVKA II Antigen Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America PIVKA II Antigen Sales Quantity by Type (2021-2032)
- 10.2 South America PIVKA II Antigen Sales Quantity by Application (2021-2032)
- 10.3 South America PIVKA II Antigen Market Size by Country
- 10.3.1 South America PIVKA II Antigen Sales Quantity by Country (2021-2032)
- 10.3.2 South America PIVKA II Antigen Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa PIVKA II Antigen Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa PIVKA II Antigen Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa PIVKA II Antigen Market Size by Country
- 11.3.1 Middle East & Africa PIVKA II Antigen Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa PIVKA II Antigen Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 PIVKA II Antigen Market Drivers
- 12.2 PIVKA II Antigen Market Restraints
- 12.3 PIVKA II Antigen Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of PIVKA II Antigen and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of PIVKA II Antigen
- 13.3 PIVKA II Antigen Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 PIVKA II Antigen Typical Distributors
- 14.3 PIVKA II Antigen Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on PIVKA II Antigen. Industry analysis & Market Report on PIVKA II Antigen is a syndicated market report, published as Global PIVKA II Antigen Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of PIVKA II Antigen market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
